id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-P-0646-0010,FDA,FDA-2014-P-0646,Draft Proposed Trazodone Oral Solution Prescribing Information re Supplement from Kamat Pharmatech,Supporting & Related Material,Background Material,2016-09-19T04:00:00Z,2016,9,,,2016-09-19T19:12:46Z,,0,0,0900006482214fbd
FDA-2014-P-0646-0009,FDA,FDA-2014-P-0646,Trazodone RLD Prescribing Information re Supplement from Kamat Pharmatech,Supporting & Related Material,Background Material,2016-09-19T04:00:00Z,2016,9,,,2016-09-19T19:11:44Z,,0,0,0900006482214e2a
FDA-2014-P-0646-0008,FDA,FDA-2014-P-0646,Kamat Pharmatech's Suitability Petition Revision,Supporting & Related Material,Background Material,2016-09-19T04:00:00Z,2016,9,,,2016-09-19T19:10:23Z,,0,0,0900006482214e29
FDA-2014-P-0646-0007,FDA,FDA-2014-P-0646,Supplement from Kamat Pharmatech,Other,Supplement (SUP),2016-09-19T04:00:00Z,2016,9,2016-09-19T04:00:00Z,,2016-09-19T19:04:33Z,,0,0,0900006482214e28
FDA-2014-P-0646-0006,FDA,FDA-2014-P-0646,Letter from Kamat Pharmatech to FDA,Other,Letter(s),2016-09-07T04:00:00Z,2016,9,2016-09-07T04:00:00Z,,2016-09-07T17:54:06Z,,0,0,09000064821ddb39
FDA-2014-P-0646-0005,FDA,FDA-2014-P-0646,Acknowledgement Letter From FDA DDM to Kamat Pharmatech,Other,Acknowledgement Letter/Receipt,2016-09-07T04:00:00Z,2016,9,2016-09-07T04:00:00Z,,2016-09-07T17:16:37Z,,0,0,09000064817030de